Skip to main content
. 2021 Jun 11;12:673532. doi: 10.3389/fimmu.2021.673532

Table 5a.

Comparison of baseline measurements of each biomarkers that changed with post-vaccination of AERAS-402.

Genes day 0 and day 7Ψ day 0 and day 28Ψ day 0 and day 35Ψ day 0 and day 42¥ day 0 and day 182¥
Mean difference SE Mean p-value Mean difference SE Mean p-value Mean difference SE Mean p-value Mean difference SE Mean p-value Mean difference SE Mean p-value
Type-1 IFN inducible CXCL10 451.7 367.9 0.265 859.4 537.4 0.161 142.7 293.0 0.643 268.4 841.1 0.470 587.5 78.6 0.001
IFI35 468.4 873.0 0.611 1671.3 1283.8 0.241 -617.0 1076.7 0.578 305.1 1077.2 0.789 2702.7 895.7 0.030
IFIT3 683.6 469.5 0.196 576.0 357.1 0.158 919.4 1218.4 0.479 118.0 476.1 0.815 1424.2 431.0 0.021
TAP2 232.1 304.9 0.475 513.7 200.4 0.043 250.0 248.1 0.353 -127.0 246.4 0.626 22.7 345.4 0.950
Hanekom set BMP6 1838.4 1822.5 0.352 995.7 1243.5 0.454 345.4 1058.1 0.755 1412.2 1173.3 0.909 3552.0 1134.9 0.026
GUSB 293.7 257.6 0.298 376.1 218.8 0.136 131.6 163.3 0.451 137.1 148.2 0.399 818.8 287.3 0.036
KIF1B 491.9 260.8 0.108 324.7 225.0 0.199 268.4 140.6 0.105 122.3 191.1 0.552 457.7 154.3 0.031
LYN 383.9 162.2 0.056 1336.7 383.2 0.013 655.3 291.2 0.065 711.2 336.4 0.088 1796.5 1036.8 0.144
VEGF -18.4 21.0 0.413 133.1 86.8 0.176 130.4 51.6 0.045 276.3 64.3 0.008 -29.8 39.5 0.484
Innate and adaptive CCL5 6127.4 2222.7 0.033 2371.1 1947.8 0.269 3833.6 1562.6 0.050 -544.1 1364.4 0.710 3306.2 2832.9 0.296
CCR7 715.3 349.6 0.087 450.3 216.6 0.083 1173.3 336.8 0.013 446.4 393.2 0.320 319.8 326.5 0.372
CD3E 3363.9 1015.1 0.016 2700.3 885.1 0.022 2821.0 954.2 0.025 671.0 1066.1 0.564 1407.0 867.2 0.166
CD8A 979.9 557.8 0.129 580.9 480.6 0.272 1470.4 515.5 0.029 37.6 586.2 0.952 497.2 781.8 0.553
CLEC7A 1627.7 696.3 0.056 1932.7 800.4 0.050 1372.4 407.9 0.015 1213.6 409.3 0.041 1907.2 595.9 0.024
CXCL13 581.1 185.3 0.020 313.6 163.8 0.104 312.0 88.6 0.012 290.0 229.4 0.275 373.8 169.6 0.079
GATA3 179.9 65.5 0.033 122.1 41.4 0.026 83.3 55.6 0.185 68.8 78.2 0.429 45.7 63.0 0.501
GZMA -734.4 720.0 0.347 -2111.6 542.5 0.008 -1690.9 688.0 0.049 -2813.0 502.2 0.005 821.8 1800.9 0.667
NLRC4 -128.1 154.4 0.438 -81.1 50.8 0.161 -358.4 110.7 0.018 389.0 452.4 0.438 417.0 321.4 0.251
NLRP1 2473.6 1179.9 0.081 2599.7 692.8 0.009 2436.4 406.2 0.001 1425.4 940.8 0.240 1971.8 1466.9 0.237
NLRP3 166.0 148.5 0.306 674.3 197.6 0.014 389.9 172.6 0.001 752.9 89.8 0.001 63.7 177.6 0.735
NOD1 321.9 169.7 0.107 390.9 153.2 0.043 256.0 66.3 0.008 46.6 264.7 0.869 258.3 143.2 0.131
PTPRCv1 3436.4 862.3 0.007 2378.7 833.5 0.029 2426.3 622.1 0.008 1613.6 914.0 0.152 2243.3 847.3 0.046
PTPRCv2 927.0 359.7 0.042 709.6 371.1 0.104 791.6 170.3 0.004 -145.0 370.2 0.716 769.8 504.9 0.188
TAGAP 2718.0 809.5 0.015 1475.1 467.7 0.020 2064.0 568.9 0.011 356.8 604.1 0.587 1906.0 713.8 0.044
TLR4 -26.9 53.8 0.636 77.6 38.2 0.088 -77.3 68.3 0.301 131.2 148.0 0.428 340.0 124.1 0.041
TLR7 -763.0 304.2 0.046 -223.0 327.8 0.522 -603.1 315.6 0.105 -257.4 682.3 0.725 290.7 193.3 0.193
ZNF331 437.0 244.6 0.124 210.4 100.0 0.080 920.1 300.4 0.022 741.0 192.4 0.018 17.3 30.6 0.596

Ψ - 7 subjects; ¥ - 6 subjects. SE, Standard error; p-value obtained based on paired t-test. The significant p-values are in bold.